SCHEMBL24951632

SCHEMBL24951632

Cc1ccc(C)c(NC(=O)c2cnc(Cl)nc2Cl)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.52
▸ LMNA P02545 3/20 0.52
▸ TSHR P16473 1/20 0.52
▸ HSD17B10 Q99714 1/20 0.52
▸ NPC1 O15118 2/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ MAPT P10636 1/20 0.51
▸ NFKB1 P19838 3/20 0.50
▸ NFKB2 Q00653 3/20 0.50
▸ RELA Q04206 3/20 0.50
▸ JUN P05412 2/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ HTT P42858 1/20 0.49
▸ MEN1 O00255 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ APOBEC3A P31941 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22145717 0.90 MAPT (0.54) RAB9ANPC1SMN1; SMN2MAPTNFKB1
SCHEMBL24952254 0.84 RAB9A (0.47) RAB9ALMNATSHRHSD17B10NPC1
SCHEMBL24951630 0.81 ALDH1A1 (0.50) RAB9ALMNANPC1SMN1; SMN2KDM4E
SCHEMBL30202869 0.81 ALDH1A1 (0.50) RAB9ALMNANPC1SMN1; SMN2KDM4E
SCHEMBL20558428 0.78 NFKB1 (0.65) KDM4EMAPTNFKB1NFKB2RELA
SCHEMBL2949398 0.77 RXFP1 (0.51) RAB9ANPC1NFKB1NFKB2RELA
SCHEMBL22145716 0.76 NPC1 (0.50) RAB9ANPC1SMN1; SMN2KDM4EMAPT
SCHEMBL22145723 0.75 BRAF (0.67) —
SCHEMBL22145341 0.74 KMT2A (0.45) KDM4EMAPTNFKB1NFKB2RELA
SCHEMBL22807419 0.74 CHRNA7 (0.54) MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023007009-A1 PYRAZOLOPYRIMIDINES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2023-02-02 — — WO disclosed
Send feedback